CO

Global Cord Blood (CO)

Global Cord Blood Corporation

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NYSE:CO

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/04/26	05 : 02	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NYSE:CO	Global Cord Blood Corporation
2024/04/17	22 : 03	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NYSE:CO	Global Cord Blood Corporation
2024/03/20	05 : 07	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NYSE:CO	Global Cord Blood Corporation
2024/03/12	05 : 01	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NYSE:CO	Global Cord Blood Corporation
2023/09/06	01 : 18	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NYSE:CO	Global Cord Blood Corporation
2023/06/22	22 : 11	Edgar (US Regulatory)	Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)	NYSE:CO	Global Cord Blood Corporation
2023/06/03	03 : 39	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NYSE:CO	Global Cord Blood Corporation
2023/04/14	04 : 14	PR Newswire (US)	GLOBAL CORD BLOOD CORPORATION ANNOUNCES FAILURE TO FILE INTERIM FINANCIALS	NYSE:CO	Global Cord Blood Corporation
2023/04/14	04 : 08	PR Newswire (US)	GLOBAL CORD BLOOD CORPORATION ANNOUNCES FAILURE TO FILE INTERIM FINANCIALS	NYSE:CO	Global Cord Blood Corporation
2023/04/11	05 : 17	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NYSE:CO	Global Cord Blood Corporation
2023/03/04	06 : 20	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NYSE:CO	Global Cord Blood Corporation
2023/02/04	04 : 39	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NYSE:CO	Global Cord Blood Corporation
2023/02/03	22 : 01	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NYSE:CO	Global Cord Blood Corporation
2022/12/03	06 : 07	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NYSE:CO	Global Cord Blood Corporation
2022/11/01	05 : 03	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NYSE:CO	Global Cord Blood Corporation
2022/10/22	06 : 15	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NYSE:CO	Global Cord Blood Corporation
2022/09/27	05 : 07	Business Wire	Global Cord Blood Corporation Announces Appointment of Joint Provisional Liquidators by The Grand Court Of The Cayman Islands	NYSE:CO	Global Cord Blood Corporation
2022/09/24	03 : 07	TipRanks	Global Cord Blood trading halted by NYSE for ‘regulatory concern’	NYSE:CO	Global Cord Blood Corporation
2022/09/24	02 : 52	Business Wire	The Grand Court of the Cayman Islands Granted Blue Ocean’s Application to Appoint Joint Provisional Liquidators for Global Cord Blood Corporation	NYSE:CO	Global Cord Blood Corporation
2022/08/24	22 : 02	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (sc 13d/a)	NYSE:CO	Global Cord Blood Corporation
2022/08/17	05 : 26	Edgar (US Regulatory)	Annual and Transition Report (foreign Private Issuer) (20-f)	NYSE:CO	Global Cord Blood Corporation
2022/08/17	05 : 16	PR Newswire (US)	Global Cord Blood Corporation Files Annual Report on Form 20-F	NYSE:CO	Global Cord Blood Corporation
2022/08/02	21 : 01	Edgar (US Regulatory)	Notification That Form 20-f Will Be Submitted Late (nt 20-f)	NYSE:CO	Global Cord Blood Corporation
2022/07/07	05 : 22	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NYSE:CO	Global Cord Blood Corporation
2022/07/07	05 : 16	PR Newswire (US)	Global Cord Blood Corporation Obtained Injunction Order Against Blue Ocean in respect of Purported EGM	NYSE:CO	Global Cord Blood Corporation
2022/07/06	05 : 16	PR Newswire (US)	Global Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2022	NYSE:CO	Global Cord Blood Corporation
2022/06/27	21 : 02	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NYSE:CO	Global Cord Blood Corporation
2022/06/23	05 : 01	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (sc 13d/a)	NYSE:CO	Global Cord Blood Corporation
2022/06/18	01 : 49	Dow Jones News	Global Cord Blood Shares Rise 15% After Merger Target Gets FDA Clearance for IND	NYSE:CO	Global Cord Blood Corporation
2022/06/17	05 : 20	PR Newswire (US)	Global Cord Blood Corporation Announced Cellenkos Receives FDA Clearance of IND Application for CK0804 as Add on Therapy to Ruxolitinib for the Treatment of Myelofibrosis	NYSE:CO	Global Cord Blood Corporation